Trial 9L-16-6


A Pilot/Safety Study of sEphB4-HSA in Combination with a Hypomethylating Agent (HMA) for Patients with Relapsed or Refractory Myelodysplastic Syndrome (MDS) and AML Previously Treated with a Hypomethylating Agent

Type: Treatment
Phase: Phase II
Status: Not Open (Closed)
Treatments: Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Casey O'Connell, M.D.
Other Trial Staff:  Ashot Minasyan, D.M., Meena Ibrahim, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.